Best pharmacological practice: urinary tract infections

Bibliography

• RUBIN RH, SHAPIRO ED, ANDRIOLE VT, DAVIS RJ,STAMM WE: Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Chit. Infect. Dis. (1992) 15\(Suppl. 0:5216–5227.
   Google Scholar
• HOOTON TM, STAMM WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis. Clinics N Am. (1997) 11:551–581.
   PubMed Web of Science ®Google Scholar
• ••Full review of acute uncomplicated UTI.
   Google Scholar
• NICOLLE LE: A practical approach to the management of complicated urinary tract infection. Drugs Aging (2001) 18:243–254.
   PubMed Web of Science ®Google Scholar
• SCHEMBRI MA, KJAERGAARD K, SOKURENKO EV, KLEMM P: Molecular characterization of the Escherichia coli FimH adhesion. j Infect. Dis. (2001) 183\(Suppl. 1):S28–S31.
   Google Scholar
• JOHNSON JR, BROWN JJ,MASLOW JN: Clonal distribution of the three alleles of the Gal (0=1-4) Gal specific gene pap G among Escherichia coli strains from patients with bacteremia.Infect. Dis. (1998) 177:651–661.
   Web of Science ®Google Scholar
• MIDDENDORF B, BLUM-OEHLER G, DOBRINDT U, MUHLDORFER I, SALGE S, HACKER J: The pathogenicity islands of the uropathogenic Escherichia coli strain 536: Island probing of PA:II.Infect.Dis. (2001) 183\(Suppl. 1):S17–S20.
   Google Scholar
• NICOLLE LE: Urinary tract pathogens in complicated urinary infection and in the elderly. j Infect. Dis. (2001) 183\(Suppl. 1): S5–S8.
   Google Scholar
• CHINN RH, MASKELL R, MEAD JA, POLAK A: Renal stones and urinary infection: a study of antibiotic treatment. Br. Med. J. (1976) 2:1411–1413.
   PubMed Web of Science ®Google Scholar
• NICOLLE LE: Measurement and significance of antibiotic activity in the urine. P793-812 In: Antibiotics in Laboratory Medicine 4th edd Lorian V (Ed.), Williams & Wilkins, Baltimore, MD, USA (1996).
   Google Scholar
• NICOLLE LE, MADSEN KS,DEBEECK GD et al.: Three days pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scam/. j Infect. Dis. (2002) 34:487–492.
   Google Scholar
• CHRISTIAENS TCM, DEMEYERE M, VERSCHRAEGEN G, PEERSMAN W, HEYTENS S, DEMAESENEER JM: Randomized controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.Br. j Gen. Practice (2002) 52:729–734.
   PubMed Web of Science ®Google Scholar
• ••Important study of the natural history ofuntreated cystitis.
   Google Scholar
• KAHLMETER G: The ECO-SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report.Antimicrob. Chen/other. (2000) a46\(Suppl. 1):515–522.
   Google Scholar
• ••Summary of current susceptibilities ofE. colito urinary tract antimicrobials, with well-characterised dinicals isolates from Europe and Canada.
   Google Scholar
• GUPTA K, SOHM DF, MAYFIELD D, STAMM WE: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Chit. Infect. Dis. (2001) 33:89–94.
   PubMed Web of Science ®Google Scholar
• WARREN JW, ABRUTYN E, HEBEL JR, JOHNSON JR, SCHAEFFER AJ, STAMM WE: Guidelines for antimicrobial treatment of uncomplicated bacterial cystitis and acute pyelonephritis in women. Chit. Infect. Dis. (1999) 29:745–758.
   PubMed Web of Science ®Google Scholar
• ••Important literature review and evidence-based recommendations.
   Google Scholar
• NICOLLE LE, HOEPELMAN AIM, FLOOR ME, VERHOEF J,NORGARD K: Comparison of three days therapy with cefcanel daloxate or amoxicillin in the treatment of acute uncomplicated urinary tract infection. Scam/. J Infect. Dis. (1993) 25:631–637.
   PubMed Web of Science ®Google Scholar
• STAMM WE, MCKEVITT M, COUNTS GW: Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks: a randomized trial.Ann. Intern. Med. (1987) 106:341–345.
   PubMed Web of Science ®Google Scholar
• CHRISTENSEN B: Which antibiotics are appropriate for treating bacteriuria in pregnancy? I Antimicrob. Chemother. (2000) 46\(Suppl. 1):29–34.
   Google Scholar
• •Review of current status of safety of antimicrobials in pregnancy.
   Google Scholar
• MASTERTON RG, BOCHSLER JA: Highdosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infectionin women. j Antimicrob. Chemother. (1995) 35:129–137.
   PubMed Web of Science ®Google Scholar
• RAZ R, ROTTENSTERICH E,BOGER S, POTASMAN I: Comparison of single-dose administration and three-day course of amoxicilliniclavulanic acid for treatment of uncomplicated urinary tract infection in women. Antimicrob. Agents Chemother. (1991) 35:1688–1690.
   PubMed Web of Science ®Google Scholar
• BRUMFITT W,HAMILTON-MILLER JMT:Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections. Antimicrob. Agents Chemother. (1990) 34:1803–1805.
   PubMed Web of Science ®Google Scholar
• BAILEY RR: Continuing problems with theuse of augmentin for urinary tract infections. NZ Med. j (1995) 108:465.
   PubMed Web of Science ®Google Scholar
• MCCARTY JM, RICHARD G, HUCK W et al.: A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprimisulfamethoxazole for the treatment of acute urinary tract infection in women. Am. J Med. (1999) 106:292–299.
   PubMed Web of Science ®Google Scholar
• GUPTA K, STAMM WE: Outcomes associated with trimethoprimi sulfamethoxazole therapy in trimethoprimisulfamethoxazole resistant community-acquired UTI. Int. J. Antimicrob. Agents. (2002) 19:554–556.
   PubMed Web of Science ®Google Scholar
• BROWN PD, FREEMAN A,FOXMAN B: Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin. Infect. Dis. (2002) 34:1061–1066.
   PubMed Web of Science ®Google Scholar
• •Describes frequency of E coil resistance in acute cystitis, and associated risk factors.
   Google Scholar
• NICOLLE LE, RONALD AR: Recurrent urinary tract infection in adult women: diagnosis and treatment.Infect. Dis. N Am. (1987) 1:793–806.
   PubMedGoogle Scholar
• TALAN DA, STAMM WE,HOOTON TM et al.: Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. j Am. Med. Assoc. (2000) 283:1583–1590.
   Google Scholar
• JOHNSON JR, LYONS MF 2nd, PEARCE W et al.: Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days. j Infect. Dis. (1991) 163:325–330.
   Google Scholar
• BAILEY RR, PEDDIC BA, BISHOP V: Comparison of single dose with a 5-day course of trimethoprim for asymptomatic (covert) bacteriuria of pregnancy.NZ Med. J. (1986) 99:501–503.
   PubMedGoogle Scholar
• STAMM WE, HOOTON TM: Management of urinary tract infections in adults. N Eng. 1. Med. (1993) 329:1328–1334.
   PubMed Web of Science ®Google Scholar
• HERNANDEZ-DIAZ S, WERLER MM, WALKER AM, MITCHELL AA: Folic acid antagomists during pregnancy and the risk of birth defects. N Eng. 1. Med. (2000) 343:1608–1614.
   Google Scholar
• GREENBERG RN, REILLY PM, LUPPEN KL, WEINANDT WJ, ELLINGTON LL, BOLLINGER MR: Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. 1. Infect. Dis. (1986) 153:277–287.
   PubMed Web of Science ®Google Scholar
• ELHANAN G, TABENKIN H, YAHALOM R, RAZ R: Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women. Antimicrob. Agents Chemother. (1994) 38:2612–2614.
   PubMed Web of Science ®Google Scholar
• IRAVANI A, DOYLE CA, DURHAM SJ, WILBER RB: Cefprozil versus cefaclor in the treatment of acute and uncomplicated urinary tract infections. Chit. Ther. (1992) 14:314–326.
   Google Scholar
• NABER KG, KOCH EM: Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Infection (1993) 21:34–39.
   PubMed Web of Science ®Google Scholar
• PFAU A, SACKS TG: Effective prophylaxis for recurrent urinary tract infections during pregnancy. Chu. Infect. Dis. (1992) 14:810–814.
   PubMed Web of Science ®Google Scholar
• ODENHOLT I, BYLANDER-GROTH A,FRIMODT-MOLLER N, ROKSTAD KS, MOLSTAD S: Differences in antibiotic prescribing patterns between general practitioners in Scandinavia: a questionnaire study. Scalar/. I Infect. Dis. (2002) 34:602–609.
   PubMed Web of Science ®Google Scholar
• LARSEN H, NIELSEN GL, MOLLER M,EBBERSEN F, SCHONHEYDER HC, SORENSEN HT: Birth outcome and risk of neonatal hypoglycemia following in utero exposure to pivmecillinam: a population-based cohort study with 414 exposed pregnancies. Scam/. I Infect. Dis. (2001) 33:439–444.
   PubMedGoogle Scholar
• NICOLLE LE: Pivmecillinam in thetreatment of urinary tract infection. ?Antimicrob. Chemother. (2000) 46\(Suppl. 1):35–40.
   Google Scholar
• IRAVANI A, KLIMBERG I, BRIERFER C,MUNERA C, KOWALSKY SEECHOLS RM: A trial comparing low-dose short-course ciprofloxacin and standard 7-day therapy with cotrimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. ?Antimicrob. Chemother. (1999) 43(Suppl. A):67–75.
   Google Scholar
• GUAY DR: An update on the role ofnitrofurantoins in the management of urinary tract infections. Drugs (2001) 61:353–364.
   PubMed Web of Science ®Google Scholar
• STEIN GE: Comparison of single-dose fosfomycin and 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Chit. Ther. (1999) 21:1864–1872.
   Google Scholar
• HOOTON TM, WINTER C, TIU STAMM WE: Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. J. Am. Med. Assoc. (1995) 273:41–45.
   PubMed Web of Science ®Google Scholar
• SPRING PJ, SHARPE DM, HAYES MW: Nitrofurantoin and peripheral neuropathy: a forgotten problem? Med. I Aust (2001) 174:153–154.
   PubMed Web of Science ®Google Scholar
• UHARI M, NUUTINEN M, TURTINEN J: Adverse reactions in children during long-term antimicrobial therapy. Pediatr. Infect. Dis. 1 (1996) 15:404–408.
   PubMed Web of Science ®Google Scholar
• BRUMFIT W, HAMILTON-MILLER JM: Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. I Antimicrob. Chemother. (1998) 42:363–371.
   PubMed Web of Science ®Google Scholar
• PATEL SS, BALFOUR JA, BRYSON HM: Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties, and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs (1997) 53:637–656.
   PubMed Web of Science ®Google Scholar
• KREMERY S, HROMEC J,DEMESOVAD: Treatment of lower urinary tract infection in pregnancy. Int. I Aritimicrob. Agents. (2001) 17:279–282.
   PubMed Web of Science ®Google Scholar
• SAGINUR R, NICOLLE LE: Single dosecompared with 3-day norfloxacin treatment of uncomplicated urinary tract infection inwomen. Canadian Infectious Diseases Society Clinical Trials Study Group. Arch. Int. Med. (1992) 152:1233–1237.
   Google Scholar
• IRAVANI A: Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am. J. Med. (1993) 94(Suppl. 3A):89–96.
   Google Scholar
• ODE B, WALDER M, FORSGREN A: Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. Scalar/ J. Infect. Dis. (1987) 19:677–679.
   PubMed Web of Science ®Google Scholar
• GARLANDO E RIETIKER S,TAUBER MG, FLEPP M, MEIER B, LUTHY R: Single-dose ciprofloxcin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob. Agents Chemother. (1987) 312:354–356.
   Google Scholar
• NABER KG, DI SILVERIOGEDDES A, GUIBERT J: Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection. J. Antimicrob. Chemother. (1996) 37(Suppl. A):135–144.
   Google Scholar
• BERRY V, PAGE R, SATTERFIELD J, SINGLEY C, STRAUB R, WOODNUTT G: Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection. ?Antimicrob. Chemother. (2000) 45\(Suppl. 1):87–93.
   Google Scholar
• ENA J, AMADOR C, MARTINEZ C,ORTIZ DE LA TABLA V: Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. ?Urol. (1995) 153:117–120.
   Google Scholar
• MANDELL L, TILLOTSON G: Safety of flouroquinolones: an update.Can. J. Infect. Dis. (2002) 13:54–61.
   PubMedGoogle Scholar
• •Review of current understanding of toxicities of flouroquinolones.
   Google Scholar
• MINASSIAN MA, LEWIS DA, CHATTOPADHYAY D, BOVILL B, DUCKWORTH GJ, WILLIAMS JD: A comparison between single dose fosfomcyin trometamol and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Inter I Antimicrob. Agents (1998) 10:39–47.
   PubMed Web of Science ®Google Scholar
• GUPTA K, HOOTON TM, STAMM WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.Ann. Intern. Med. (2001) 135:41–50.
   PubMed Web of Science ®Google Scholar
• ••Discusses the evolution of resistance andpotential impact on management.
   Google Scholar
• BENT S, SAINTS: The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am. j Med. (2002) 113(Suppl. 1A):20–28.
   Google Scholar
• MCISAAC WJ, LOW DE, BIRINGER A, PIMLOTT N, EVANS M, GLAZIER R: The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch. Intern. Med. (2002) 162:600–603.
   PubMedGoogle Scholar
• •Discusses potential excess antimicrobial use because of failure to obtain pre-therapy culture in acute cystitis.
   Google Scholar
• ELKHARRAT D, CHASTANG C, BOUDIAF M, LECORRE A,RASKINE L, CAULIN C: Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis.Eur. Emerg. Med. (1999) 6:15–20.
   PubMedGoogle Scholar
• WRIGHT SW, WRENN KD,HAYNES M, HAAS DW: Prevalence and risk factors for multidrug resistant uropathogens in ED patients.Am. J. Emerg. Med. (2000) 18:143–146.
   PubMed Web of Science ®Google Scholar
• •Describes risk factors for resistance in a population of predominantly complicated urinary infection patients.
   Google Scholar
• LINDEN PK: Treatment options for vancomycin-resistant enterococcal infections. Drugs (2002) 62:425–441.
   PubMed Web of Science ®Google Scholar
• NICOLLE LE: Asymptomatic bacteriuria in the elderly. Infect. Dis. Clinics N Am. (1997) 11:647–662.
   PubMed Web of Science ®Google Scholar
• KEMPER KJ, AVNER ED: The case against screening urinalysis for asymptomatic bacteriuria in children. Am. J. Dis. Child. (1992) 146:343–346.
   PubMedGoogle Scholar
• CARDENAS DD, HOOTON TM: Urinary tract infection in persons with spinal cord injury. Arch. Phys. Med. Rehabil (1995) 76:272–280.
   PubMed Web of Science ®Google Scholar
• HARDING GKM, ZHANEL GG, NICOLLE LE, CHEANG M: Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. ManitobaDiabetic Urinary Infection Study Group. N. Engl. J. Med. (2002) 347:1576–1583.
   PubMed Web of Science ®Google Scholar
• NICOLLE LE: Screening for asymptomatic bacteriuria in pregnancy. P100-106. The Canadian task force on the periodic health examination. The Canadian guide to clinical preventive health care. Canada Communication Group, Ottawa, Canada (1994).
   Google Scholar
• ROMERO R, OYARZUN E, MAZOR M, SIRLORI M, HOBBINS JC,BRACKEN M: Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet. Grieco]. (1989) 73:576–582.
   Google Scholar
• GRATACOS E, TORRES J-J, VILA J, ALONSO PL, CARARACH V: Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. ?Infect. Dis. (1994) 169:1390–1392.
   PubMed Web of Science ®Google Scholar
• STENQVIST K, DAHLERN-NILSSON I, LIDEN-JANSON G et al: Bacteriuria in pregnancy. Frequency and risk of acquisition. Am. j Epidemiol (1989) 129:372–379.
   PubMed Web of Science ®Google Scholar
• SCHAEFER C, AMOURA-ELEFANT E, VIAL T et al.: Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European network of teratology information services.Eur. j Obstet. Cynecol Reprod. Biol. (1996) 69:83–89.
   Google Scholar
• SYNDMAN DR: Post transplant microbiologic surveillance. Clin. Infect. Dis. (2001) 33\(Suppl. 1): 22–25.
   Google Scholar
• GRABE M: Perioperative antibiotic prophylaxis in urology.Cun: Opin. Ural. (2001) 11:81–85.
   PubMedGoogle Scholar
• HOOTON TM, SCHOLEES D, STAPLETON AE et al.: A prospective study of asymptomatic bacteriuria in sexually active young women.New Eng]. J. Med. (2000) 343:991–997.
   Web of Science ®Google Scholar
• WARREN JW, ANTHONY WC, HOOPES JM, MUNCIE HL JR: Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. J. Am. Med. Assoc. (1982) 240:454–458.
   Google Scholar
• WESTENFELDER SR, WELLING G, MADSEN PO: Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Infection (1974) 2:76–79.
   PubMed Web of Science ®Google Scholar
• KEOGH B, RUDDOCK G, IRWIN J, WATSON A, KEANE CT: Treatment of urinary tract infection with cefuroxime in patients with renal failure. Ir. Med. j (1981) 74:205–207.
   PubMedGoogle Scholar
• BAILEY RR, PEDDIE B, BLAKE E: Serum and urine concentrations of cefoperazone in severe chronic renal failure. Drugs (1981) 22\(Suppl. 1):46–51.
   Google Scholar
• BENNETT WM, CRAVEN R: Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole.J. Am. Med. Assoc. (1976) 236:946–948.
   PubMed Web of Science ®Google Scholar
• MELEKOS MD, ASBACH HW, GERHARZ E, ZARAKOVITIS IE, WEINGAERTNER K, NABER KG: Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in pre-menopausal women. ?Ural. (1997) 157:935–939.
   Google Scholar
• NICOLLE LE, HARDING GKM, THOMPSON M, KENNEDY J, URIAS B, RONALD AR: Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women. Antimicrob. Agents Chemother. (1989) 33:1032–1035.
   PubMed Web of Science ®Google Scholar
• PFAU A, SACKS TG: Effective prophylaxisfor recurrent urinary tract infections during pregnancy. Clin. Infect. Dis. (1992) 14:810–814.
   PubMed Web of Science ®Google Scholar